Lidwine W. Tick

Neoadjuvant chemotherapy with or without anthracyclines in the presence of dual HER2 blockade for HER2-positive breast cancer (TRAIN-2): a multicentre, open-label, randomised, phase 3 trial

Mette S. van Ramshorst, Anna van der Voort, Erik van Werkhoven et al. · The Lancet Oncology · 2018 · 413 citations · Full text

Breast Oncology, Oncology, Dual Her2 Blockade +7

Radiotherapy for Graves' orbitopathy: randomised placebo-controlled study

Maarten P. Mourits, M. Loes van Kempen-Harteveld, M Begoña García García et al. · The Lancet · 2000 · 289 citations

Neuro-oncology, Radiation Therapy, Medicine +3

Further validation and simplification of the Wells clinical decision rule in pulmonary embolism

Maaike Söhne, Marieke J.H.A. Kruip, Lidwine W. Tick et al. · Thrombosis and Haemostasis · 2007 · 238 citations · Full text

Risk factors for post‐thrombotic syndrome in patients with a first deep venous thrombosis

Lidwine W. Tick, Mark H.H. Kramer, Frits R. Rosendaal et al. · Journal of Thrombosis and Haemostasis · 2008 · 222 citations · Full text

Pulmonary Embolism, Thrombosis, Venous Disease +11

Ultrasound-accelerated catheter-directed thrombolysis versus anticoagulation for the prevention of post-thrombotic syndrome (CAVA): a single-blind, multicentre, randomised trial

Pascale Notten, Arina J. ten Cate‐Hoek, Carsten W. K. P. Arnoldussen et al. · The Lancet Haematology · 2019 · 212 citations · Full text

Pulmonary Embolism, Thrombosis, Venous Thrombosis +11